- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00712088
Project ICARE: Intervening for Community Awareness, Respect, & Empowerment
March 10, 2010 updated by: Centers for Disease Control and Prevention
Project ICARE: Intervening for Community Awareness, Respect, & Empowerment - Behavioral Intervention to Reduce Sexual Risk Behavior of African American Men Who Have Sex With Men
This project will test the efficacy of a behavioral intervention to reduce sexual risk for HIV infection among African American Men who Have Sex with Men (MSM).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
275
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60613
- Howard Brown Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Be 18 years of age or older;
- Self-identify as African American
- Understand and read English;
- Live within the Chicago area;
- Report at least two (male or female) sex partners in the past three months, and unprotected anal sex with at least one male sex partner in the past three months.
Exclusion Criteria:
- Have been diagnosed with HIV within the past three months (to allow for psychological and behavioral adjustment following an initial HIV diagnosis);
- Have a specific plan to move from the Chicago area within the next nine months;
- Report active injection drug use other than hormones or steroids.
- Participated in the intervention video or the pilot phase of this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1: Group Intervention
Group level intervention
|
Group-level intervention (Project ICARE)
Other Names:
|
Active Comparator: 2: HCT
Offer of HIV counseling and testing
|
Offer of HIV counseling and testing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Unprotected Sex
Time Frame: past three months
|
past three months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: David McKirnan, PhD, University of Illinois at Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
March 1, 2010
Study Registration Dates
First Submitted
June 3, 2008
First Submitted That Met QC Criteria
July 8, 2008
First Posted (Estimate)
July 9, 2008
Study Record Updates
Last Update Posted (Estimate)
March 11, 2010
Last Update Submitted That Met QC Criteria
March 10, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDC-NCHHSTP-5159
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on HCT
-
University of South CarolinaDuke University; Kilimanjaro Christian Medical Centre, TanzaniaCompletedHIV TestingUnited States, Tanzania
-
The First Affiliated Hospital of Soochow UniversityZhejiang University; The Second People's Hospital of Huai'an; Soochow Hopes Hematology... and other collaboratorsCompletedAcute Myeloid Leukemia | Hematopoietic Stem Cell Transplantation | Haplo-identical Donor | Cord Blood UnitChina
-
The First Affiliated Hospital of Soochow UniversityFirst Affiliated Hospital Xi'an Jiaotong University; Ruijin Hospital; Wuhan Union... and other collaboratorsRecruitingHaploidentical Hematopoietic Stem Cell Transplantation | Cord Blood | Acute T Cell Lymphoblastic LeukemiaChina
-
Centers for Disease Control and PreventionUniversity of Miami; Nova Southeastern University; DePaul UniversityCompletedHIV InfectionsUnited States
-
Joanne Kurtzberg, MDThe Marcus FoundationCompletedAutism Spectrum Disorder | Autism | ASDUnited States
-
John MascarenhasNational Cancer Institute (NCI); Novartis; Incyte Corporation; Myeloproliferative...TerminatedPrimary Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Canada, United Kingdom
-
Duke UniversityThe Marcus FoundationCompletedAutism Spectrum DisorderUnited States
-
Joanne Kurtzberg, MDDuke Clinical and Translational Science Institute (CTSI), part of the NIH...CompletedModerate to Severe Hypoxic-ischemic EncephalopathyUnited States
-
Duke UniversityCompletedStem Cell TransplantUnited States
-
VIVEX Biologics, Inc.TalosixTerminated